Wei Li, Founder of CytoLynx Therapeutics

Wei Li is the founder of CytoLynx Therapeutics. CytoLynx Therapeutics has raised $45M in total funding. Latest round: Series A.

About Wei Li

Dr. Wei Li is a biopharmaceutical researcher and executive. He serves as Chief Scientific Officer at Cytovia Therapeutics, a company focused on gene-edited NK cell therapies. He was involved in the formation of CytoLynx Therapeutics, a China-focused joint venture of Cytovia.

Wei Li at a glance

More founder profiles (44)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library